Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female outpatient of 18 years of age or greater
Stage 2 systolic hypertension defined as office Mean Sitting Systolic blood pressure (MSSBP) greater than or equal to 160 and \< 200 mmHg at randomization
Patients who were able to participate in the study, and who gave written informed consent before any study assessment was performed.
You may not be if
Office systolic blood pressure \>200 and/or mean sitting diastolic blood pressure (MSDBP) greater than or equal to 110 mmHg at Visit 1.
Use of four (4) or more antihypertensive medications within 30 days of Visit 1.
Refractory hypertension, defined as blood pressure \>140/90 mmHg while taking three (3) drugs at the maximum dose of each drug, one of which must be a diuretic. (Therapy with a fixed-dose combination of two active medications represents two drugs).
Inability to safely discontinue all antihypertensive medications for 1-2 weeks prior to randomization.
Clareo Health | Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension